FEIBA® Reversal for Apixaban and Rivaroxaban in Patients with Intracranial and Non-intracranial Hemorrhages
Aleah R. Hunt, Shawn N. Coffeen, View ORCID ProfileDane L. Shiltz, View ORCID ProfileCalvin Ice, Jessica Parker
doi: https://doi.org/10.1101/2020.08.19.20178061
Aleah R. Hunt
Spectrum Health Butterworth Hospital;
PharmDShawn N. Coffeen
PharmD
Dane L. Shiltz
PharmD, BCPS
Calvin Ice
PharmD, BCPS, BCCPS
Data Availability
The data included in the manuscript has been deidentified and retained on an internal redCAP database.
Posted August 25, 2020.
FEIBA® Reversal for Apixaban and Rivaroxaban in Patients with Intracranial and Non-intracranial Hemorrhages
Aleah R. Hunt, Shawn N. Coffeen, Dane L. Shiltz, Calvin Ice, Jessica Parker
medRxiv 2020.08.19.20178061; doi: https://doi.org/10.1101/2020.08.19.20178061
Subject Area
Subject Areas
- Addiction Medicine (316)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2296)
- Dermatology (202)
- Emergency Medicine (371)
- Epidemiology (11619)
- Forensic Medicine (10)
- Gastroenterology (683)
- Genetic and Genomic Medicine (3621)
- Geriatric Medicine (340)
- Health Economics (622)
- Health Informatics (2329)
- Health Policy (918)
- Hematology (336)
- HIV/AIDS (758)
- Medical Education (361)
- Medical Ethics (101)
- Nephrology (393)
- Neurology (3389)
- Nursing (193)
- Nutrition (512)
- Oncology (1776)
- Ophthalmology (526)
- Orthopedics (211)
- Otolaryngology (284)
- Pain Medicine (226)
- Palliative Medicine (66)
- Pathology (441)
- Pediatrics (1012)
- Primary Care Research (409)
- Public and Global Health (6019)
- Radiology and Imaging (1237)
- Respiratory Medicine (813)
- Rheumatology (370)
- Sports Medicine (319)
- Surgery (390)
- Toxicology (50)
- Transplantation (171)
- Urology (143)